Zuojia Liu

8PUBLICATIONS
1CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionCancer diagnosisMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 20, 2025
Targeting KRAS Sensitizes Ferroptosis by Coordinately Regulating the TCA Cycle and Nrf2-SLC7A11-GPX4 Signaling in Hepatocellular Carcinoma.

Jiaxin Zhang, Zuojia Liu, Wenjing Zhao

|Feb 11, 2023
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease.

Xunzhe Yin, Xiangyu Guo, Zuojia Liu

|Dec 23, 2022
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment.

Xiangyu Guo, Xunzhe Yin, Zuojia Liu

|Dec 11, 2022
Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future.

Chang Li, Xunzhe Yin, Zuojia Liu

|Oct 27, 2022
Targeting KRAS in PDAC: A New Way to Cure It?

Qianyu He, Zuojia Liu, Jin Wang

|Dec 23, 2021
AMPK-Mediated Metabolic Switching Is High Effective for Phytochemical Levo-Tetrahydropalmatine (l-THP) to Reduce Hepatocellular Carcinoma Tumor Growth.

Xunzhe Yin, Wenbo Li, Jiaxin Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Qianyu He